Neurochemical aftermath of amateur boxing
暂无分享,去创建一个
Å. Edman | L. Wahlund | I. Karlsson | K. Blennow | H. Zetterberg | M. Jonsson | M. A. Hietala | A. Rasulzada | C. Popa | E. Styrud | N. Andreasen | P. Mehta | L. Rosengren | A. Wallin
[1] K. Blennow,et al. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study , 2006, The Lancet Neurology.
[2] K. Blennow,et al. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome , 2006, Journal of the Neurological Sciences.
[3] K. Jellinger. Head injury and dementia , 2004, Current opinion in neurology.
[4] N. Norgren,et al. Neurofilament and glial fibrillary acidic protein in multiple sclerosis , 2004, Neurology.
[5] I. Grundke‐Iqbal,et al. Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. , 2002, The American journal of pathology.
[6] I. Grundke‐Iqbal,et al. Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients , 2002, Neuroscience Letters.
[7] K. Blennow,et al. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke , 2001, Neuroscience Letters.
[8] K. Blennow,et al. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization , 2000, Neuroscience Letters.
[9] K. Blennow,et al. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. , 1999, Archives of neurology.
[10] C. Wikkelsø,et al. Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF , 1996, Journal of neurochemistry.
[11] K. Blennow,et al. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? , 1995, Molecular and chemical neuropathology.
[12] C. Wikkelsø,et al. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults , 1994, Journal of Neuroscience Methods.
[13] M. Goedert. Tau protein and the neurofibrillary pathology of Alzheimer's disease , 1993, Trends in Neurosciences.
[14] Ejnar Eriksson,et al. Does amateur boxing lead to chronic brain damage? , 1993, The American journal of sports medicine.
[15] C. Gillberg,et al. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children , 1992, Journal of Neuroscience Methods.
[16] D. Allsop,et al. The occult aftermath of boxing. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[17] I. Casson,et al. Brain damage in modern boxers. , 1984, JAMA.
[18] C. Bruton,et al. The aftermath of boxing , 1973, Psychological Medicine.
[19] R. Friede,et al. Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice , 1970, The Anatomical record.
[20] G. Will. “Punch Drunk” , 1939 .
[21] L. Goodwin. Dementia pugilistica. , 2006, Journal of insurance medicine.
[22] H. Wiśniewski,et al. Plasma and cerebrospinal fluid Levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease , 2000 .
[23] B. Jordan,et al. Chronic Traumatic Brain Injury Associated with Boxing , 2000, Seminars in neurology.
[24] P. Kemp. A critique of published studies into the effects of amateur boxing: why is there a lack of consensus? , 1995, Journal of the Royal Naval Medical Service.
[25] Kemp Pl. A critique of published studies into the effects of amateur boxing: why is there a lack of consensus? , 1995 .